Covered recipient · General Payments record
BIKAS SHARMA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,738.68
- Reported across 154 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $613.76 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $392.83 | 26 |
| Almatica Pharma Inc. | $149.78 | 7 |
| Novo Nordisk AS | $71.15 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.11 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074924 | CMS |
| ABBVIE INC. | $23.84 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074926 | CMS |
| ABBVIE INC. | $8.89 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074928 | CMS |
| ABBVIE INC. | $5.77 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074930 | CMS |
| ABBVIE INC. | $30.52 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074932 | CMS |
| ABBVIE INC. | $7.06 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074934 | CMS |
| ABBVIE INC. | $10.83 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074936 | CMS |
| ABBVIE INC. | $15.16 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074938 | CMS |
| ABBVIE INC. | $8.72 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074940 | CMS |
| ABBVIE INC. | $21.89 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074942 | CMS |
| ABBVIE INC. | $7.40 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074944 | CMS |
| ABBVIE INC. | $5.88 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074946 | CMS |
| ABBVIE INC. | $17.40 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074948 | CMS |
| ABBVIE INC. | $9.59 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074950 | CMS |
| ABBVIE INC. | $17.99 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074952 | CMS |
| ABBVIE INC. | $15.21 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074954 | CMS |
| ABBVIE INC. | $20.38 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074956 | CMS |
| ABBVIE INC. | $30.78 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074958 | CMS |
| ABBVIE INC. | $27.45 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074960 | CMS |
| ABBVIE INC. | $11.92 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074962 | CMS |
| ABBVIE INC. | $13.93 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074964 | CMS |
| ABBVIE INC. | $9.50 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074966 | CMS |
| ABBVIE INC. | $23.77 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074968 | CMS |
| ABBVIE INC. | $13.88 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074970 | CMS |
| ABBVIE INC. | $11.76 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074972 | CMS |
| ABBVIE INC. | $6.20 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106074974 | CMS |
| Almatica Pharma LLC | $25.64 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578394 | CMS |
| Almatica Pharma LLC | $20.50 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578399 | CMS |
| Almatica Pharma LLC | $16.26 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578403 | CMS |
| Almatica Pharma LLC | $21.07 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578408 | CMS |
| Almatica Pharma LLC | $23.04 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578412 | CMS |
| Almatica Pharma LLC | $20.35 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578416 | CMS |
| Almatica Pharma LLC | $22.92 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578421 | CMS |
| Novo Nordisk Inc | $24.53 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096809084 | CMS |
| Novo Nordisk Inc | $13.71 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097661229 | CMS |
| Novo Nordisk Inc | $32.91 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599863 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.